Nurosene Health Inc.
Share · CA64132U1003 (XCNQ)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Nurosene Health Inc.
No Price
Company Profile for Nurosene Health Inc. Share
Nurosene Inc., a technology-driven wellness company, focuses on developing a line of proprietary nutraceuticals in Canada. It develops nutraceuticals, including Nuro Drive, a product to enhance physical and cognitive energy levels; Nuro Restore, a product to improve sleep, as well as reduce stress, and pain and inflammation. The company is also developing a virtual care mobile application to provide continuous support to those suffering from mental health issues. Nurosene Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.
Company Data
Name Nurosene Health Inc.
Company Nurosene Health Inc.
Website
https://www.nurosene.com
Primary Exchange 
CSE LISTED
CSE LISTED
ISIN CA64132U1003
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO George Achilleos
Country Canada
Currency CAD
Employees -
Address 1655 Dupont Street, M6P 3T1 Toronto
IPO Date 2021-06-09
Ticker Symbols
| Name | Symbol |
|---|---|
| CSE LISTED | MEND.CN |
More Shares
Investors who hold Nurosene Health Inc. also have the following shares in their portfolio:
